Ms. Amy Strater, MPH, MBA

Ms. Amy Strater

MPH, MBA

United States

Ms. Amy Strater, MPH, MBA

Ms. Amy Strater

MPH, MBA
Introduction
Metrics

4

Publications

458

Profile Views

70

Reads

23

PubMed Central Citations

Publications

4Publications

70Reads

23PubMed Central Citations

Improved coding of postoperative deep vein thrombosis and pulmonary embolism in administrative data (AHRQ Patient Safety Indicator 12) after introduction of new ICD-9-CM diagnosis codes.

Med Care 2015 May;53(5):e37-40

*Department of Medicine, Center for Healthcare Policy and Research, UC Davis School of Medicine, Sacramento †Center for Innovation and Improvement Science, University of California, San Diego ‡Center for Healthcare Policy and Research, University of California-Davis, Sacramento, CA §UHC, Chicago, IL.

View Article
May 2015
14 Reads
8 PubMed Central Citations(source)
3.23 Impact Factor

Mechanical and suboptimal pharmacologic prophylaxis and delayed mobilization but not morbid obesity are associated with venous thromboembolism after total knee arthroplasty: a case-control study.

J Hosp Med 2012 Nov-Dec;7(9):665-71. Epub 2012 Oct 5.

School of Medicine, Department of Internal Medicine, Division of General Medicine, Chicago, IL, USA.

View Article
May 2013
14 Reads
2 PubMed Central Citations(source)
2.08 Impact Factor

Variation in academic medical centers' coding practices for postoperative respiratory complications: implications for the AHRQ postoperative respiratory failure Patient Safety Indicator.

Med Care 2012 Sep;50(9):792-800

Department of Surgery, University of California Davis Medical Center, Sacramento, CA 95817, USA.

View Article
September 2012
31 Reads
2 PubMed Central Citations(source)
3.23 Impact Factor

Hospital discharge documentation and risk of rehospitalisation.

BMJ Qual Saf 2011 Sep 22;20(9):773-8. Epub 2011 Apr 22.

Division of Hospital Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

View Article
September 2011
11 Reads
11 PubMed Central Citations(source)
3.99 Impact Factor